Synta to be Showcased in Congress as One of 13 Innovative Companies Seeking More Competitive American Business Environment

September 12, 2011

LEXINGTON, MA – September 8, 2011 – Synta Pharmaceuticals Corp. (NASDAQ: SNTA) today announced that President and CEO Safi Bahcall, Ph.D. is meeting with House leaders to discuss policy initiatives that could support job creation and innovation in theU.S. economy.  Synta is among 13 companies that are being highlighted as an example of innovative firms that are being hampered by government in their effort to create American jobs.


“MaintainingU.S.leadership in science and technology and addressing the serious healthcare issues facing this country require policies in place that encourage innovation,” said Dr. Bahcall.  “Reducing the barriers and increasing incentives to innovation can help companies like Synta and other biotechnology companies create new drugs, lower the total costs of healthcare by preventing expensive hospital stays and create new jobs inAmerica.”


Dr. Bahcall will attend the President’s Address to a Joint Session of Congress this evening as a guest in the Speaker’s Box.


About Synta Pharmaceuticals


Synta Pharmaceuticals Corp. is a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to extend and enhance the lives of patients with severe medical conditions, including cancer and chronic inflammatory diseases.  Synta has a unique chemical compound library, an integrated discovery engine, and a diverse pipeline of clinical- and preclinical-stage drug candidates with distinct mechanisms of action and novel chemical structures.  All Synta drug candidates were invented by Synta scientists using our compound library and discovery capabilities.  For more information, please visit


Membership Deliverables

MassBio Membership gives you:

Purchasing power-MassBio negotiates a broad-based collection of services on behalf of member companies and passes the savings on to its members. 

Networking and professional development-MassBio organizes and executes numerous conferences, committee meetings, and networking events throughout the year.

MassBio Signature Events-Attend our Investors Forum, Innovator Roundtables, Pharma Days, our Golf Classic Fundraiser, Policy Leadership Breakfast, and many others.

Public policy & Advocacy-As the state's leading advocate for our life science super cluster, we fight for public policy initiatives and tax incentives in Massachusetts and Washington, D.C., that will enable biotechnology companies to do their best work.

Economic development-MassBio provides expert advice and guidance to help companies find suitable locations and resources as they move to and grow in the Bay State. We make Massachusetts a better place for your business.

Visibility/Resources-Members are listed on a searchable directory that includes a profile and link to the company's website. We highlight your company's latest news by posting to our MassBio member news page. In addition, members can post job openings on our website free!

Educational incentives-We promote education, workforce development and lifelong learning through the MassBioEd Foundation. The foundation customizes training programs for companies and educational institutions and promotes science in the classroom through BioTeach. MassBio members receive a discount on courses offered by the foundation.